Abnormal Expression of Prostaglandins E2 and F2αReceptors and Transporters in Patients with Endometriosis
article
OA: hybrid
CC0
⤵ 16 in-corpus citations
AI-generated summary
This study found increased expression of prostaglandin E2 and F2α receptors and transporters in the ectopic and eutopic endometrium of women with endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE: To investigate the level of expression of prostaglandin receptivity and uptake factors in eutopic and ectopic endometrium of women with endometriosis. DESIGN: Prospective study. SETTING: Human reproduction research laboratory. PATIENTS: Seventy-eight patients with endometriosis and thirty healthy control subjects. INTERVENTION(S): Endometrial and endometriotic tissue samples were obtained during laparoscopic surgery. MAIN OUTCOME MEASURE(S): Real-time polymerase chain reaction assay of mRNA encoding prostaglandin E2 receptors (EP1, EP2, EP3, and EP4), prostaglandin F2α receptor (FP), prostaglandin transporter (PGT), and multidrug resistance-associated protein 4 (MRP4); immunohistochemical localization of expressed proteins. RESULTS: Marked increases in receptors EP3, EP4, and FP and transporters PGT and MRP4 in ectopic endometrial tissue were noted, without noticeable change associated with disease stage. An increase in EP3 expression and decreases in FP and PGT were observed in the eutopic endometrium of endometriosis patients in conjunction with the phases of the menstrual cycle. CONCLUSION(S): This study is the first to demonstrate a possible relationship between endometriosis and enhanced prostaglandin activity. In view of the wide range of prostaglandin functions, increasing cell receptivity and facilitating uptake in endometrial tissue could contribute to the initial steps of overgrowth and have an important role to play in the pathogenesis and symptoms of this disease.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (70)
- Cyclooxygenase-2 Regulates Survival, Migration, and Invasion of Human Endometriotic Cells through Multiple Mechanisms via openalex
- Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis via openalex
- ENDOGENOUS PROSTAGLANDINS IN DYSMENORRHEA AND THE EFFECT OF PROSTAGLANDIN SYNTHETASE INHIBITORS (PGSI) ON UTERINE CONTRACTILITY via openalex
- Endometrial and Myometrial Prostaglandin Release during the Menstrual Cycle in Relation to Menstrual Blood Loss* via openalex
- Endometriosis via openalex
- Endometriosis: disease pathophysiology and the role of prostaglandins via openalex
- Etiology of infertility in monkeys with endometriosis: Measurement of peritoneal fluid prostaglandins via openalex
- [Expression of cylooxygenase-2 in endometriosis]. via openalex
- Identification of multiple and distinct defects in prostaglandin biosynthetic pathways in eutopic and ectopic endometrium of women with endometriosis via openalex
- Peritoneal fluid 6‐keto‐prostaglandin FL<sub>α</sub>, thromboxane B2 in endometriosis and unexplained infertility via openalex
- Peritoneal fluid prostaglandins and prostanoids in women with endometriosis, chronic pelvic inflammatory disease, and pelvic pain via openalex
- Peritoneal fluid prostaglandins in endometriosis, tubal disorders, and unexplained infertility. via openalex
- Peritoneal Fluid Prostaglandins in Patients with Endometriosis via openalex
- Peritoneal fluid prostaglandins in various stages of the menstrual cycle: role in infertile patients with endometriosis. via openalex
- Prostaglandin E<sub>2</sub> Induces Fibroblast Growth Factor 9 via EP3-Dependent Protein Kinase Cδ and Elk-1 Signaling via openalex
- Prostaglandin receptor signalling and function in human endometrial pathology via openalex
- Selective Inhibition of Prostaglandin E2 Receptors EP2 and EP4 Inhibits Adhesion of Human Endometriotic Epithelial and Stromal Cells Through Suppression of Integrin-Mediated Mechanisms1 via openalex
- Selective inhibition of prostaglandin E2 receptors EP2 and EP4 inhibits invasion of human immortalized endometriotic epithelial and stromal cells through suppression of metalloproteinases via openalex
- STUDIES IN THE INVOLVEMENT OF PROSTAGLANDINS IN UTERINE SYMPTOMATOLOGY AND PATHOLOGY via openalex
- The peritoneal environment in endometriosis via openalex
- Up-Regulation of Cyclooxygenase-2 Expression and Prostaglandin E2 Production in Human Endometriotic Cells by Macrophage Migration Inhibitory Factor: Involvement of Novel Kinase Signaling Pathways via openalex
- W2045406037 via openalex
- W2074126807 via openalex
- W2075751134 via openalex
- W2081688069 via openalex
- W2087744847 via openalex
- W2092745817 via openalex
- W2098543994 via openalex
- W2107364509 via openalex
- W2107369202 via openalex
- W2107969401 via openalex
- W2109606512 via openalex
- W2121612337 via openalex
- W2130131308 via openalex
- W2135982275 via openalex
- W2136775098 via openalex
- W2150827512 via openalex
- W2158087731 via openalex
- W2162537800 via openalex
- W2410098944 via openalex
- W2418067841 via openalex
- W2471510443 via openalex
- W2473864899 via openalex
- W3067153802 via openalex
- W4230437325 via openalex
- W4233138904 via openalex
- W4237504024 via openalex
- W4245340407 via openalex
- W26803479 via openalex
- W4250694871 via openalex
- W85930945 via openalex
- W1557147130 via openalex
- W1968148240 via openalex
- W1970066954 via openalex
- W1970873002 via openalex
- W1970980292 via openalex
- W1972701941 via openalex
- W1981183680 via openalex
- W1981263394 via openalex
- W1983112957 via openalex
- W1997246656 via openalex
- W2001779498 via openalex
- W2002547149 via openalex
- W2005650140 via openalex
- W2009570759 via openalex
- W2017239380 via openalex
- W2019380676 via openalex
- W2043582769 via openalex
- W2044204905 via openalex
- W2044939825 via openalex
Cited by (16)
- Unraveling the role of lncRNA in Endometriosis-Associated immune system Dysregulation: Exploring the intricate immunological changes and disrupted signaling pathways 2025
- Molecular Interactions of Genistein as a Potential Anti-Endometriosis 2025
- Diagnostic Value of Menstrual Blood Lipidomics in Endometriosis: A Pilot Study 2024
- Diagnostic Value of Menstrual Blood Lipidomics in Endometriosis: A Pilot Study 2024
- Catamenial pneumothorax: A population-based study 2023
- Endometriosis-associated infertility: From pathophysiology to tailored treatment 2022
- Higher fibrotic content of endometriotic lesions is associated with diminished prostaglandin E2 signaling 2021
- Changing prostaglandin E2 (PGE<sub>2</sub>) signaling during lesional progression and exacerbation of endometriosis by inhibition of PGE<sub>2</sub> receptor EP2 and EP4 2021
- Involvement of bradykinin and bradykinin B1 receptor in patients with endometriosis 2021
- Endometriosis-related chronic pelvic pain: A mini review on pathophysiology and impact on mental health 2020
- Chronic Niche Inflammation in Endometriosis-Associated Infertility: Current Understanding and Future Therapeutic Strategies 2018
- Dysfunctional signaling underlying endometriosis: current state of knowledge 2018
- Endometriosis Is a Cause of Infertility. Does Reactive Oxygen Damage to Gametes and Embryos Play a Key Role in the Pathogenesis of Infertility Caused by Endometriosis? 2018
- Prostaglandin E2 receptor EP1 in healthy and diseased human endometrium 2017
- Hypoxia-inducible factor-1alpha: A promising therapeutic target in endometriosis 2016
- Augmented Angiogenic Factors Expression via FP Signaling Pathways in Peritoneal Endometriosis 2016
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:17:46.044120+00:00
License: CC0
· commercial use OK